Effect of Ayurvedic Detox Therapies (Virechana and Vamana) in Managing Irritable Bowel Syndrome (IBS)

A Comparative Pre Post Intervention Study to Evaluate the Efficacy of Virechana Karma and Vaman Karma in the Management of Pittaja Grahani with Special Reference to Irritable Bowel Syndrome (IBS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103967

Enrollment

Registered

2026-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K580- Irritable bowel syndrome with diarrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with IBS-D as per Rome IV criteria [2] Concurrent diagnosis of Pittaja Grahani based on classical Ayurvedic lakshanas Willingness to provide written informed consent

Exclusion criteria

Exclusion criteria: Presence of organic gastrointestinal diseases (ruled out by appropriate investigations) Severe systemic illnesses (cardiac, renal, hepatic disorders) Pregnancy or lactation Psychiatric illness interfering with study compliance Patients deemed unfit for Panchakarma procedures after clinical assessment

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the effect of Virechan Karma and Vaman Karma on disease severity in patients with Pittaja Grahani (IBS-D)Timepoint: 16 week	—

Secondary

Measure	Time frame
To evaluate compare the effect of Virechan Karma or Vaman Karma more effective on disease severity in patients with Pittaja Grahani (IBS-D)Timepoint: 16 week	—

Countries

India

Contacts

Public ContactDr Ravi Dutt Sharma

Glocal college of Ayurvedic Medical sciences and Research Center

dr.lailaashok@gmail.com9447388866

Outcome results